New York licenses GMO Internet to issue the first JPY-pegged stablecoin

The New York Department of Financial Services (NYDFS) has approved Tokyo-based GMO Internet to launch GYEN, the first stablecoin pegged to the Japanese yen.

GMO Internet, an internet conglomerate that offers a large array of services, including domain hosting, online advertising and what it claims is the world’s largest foreign exchange trading platform, will set up GMO-Z.com Trust Company (GMO Trust) to issue GYEN and ZUSD, a USD-pegged stablecoin. Both will start selling outside of Japan next month.

In a press announcement, GMO Trust said it had also made strategic partnerships with global digital asset exchanges to ensure the liquidity of the virtual currencies. Began developing GYEN in 2018.

The Biden administration can change the world with new crypto regulations

GMO Trust joins about two dozen other companies that have received virtual currency licenses, also called BitLicenses, from the NYSDFS. BitLicenses, which went into effect in June 2015, are required to engage in virtual currency business activities in New York. Other companies based in Asia that hold BitLicenses include Japan’s bitflyer, a Bitcoin exchange, and Hong Kong-based digital wallet Xapo.

PayPal to let you buy and sell cryptocurrencies in the US



from TechCrunch https://ift.tt/3aSCVvp
via IFTTT

Comments

Post a Comment

Popular posts from this blog

6 investors discuss why AI is more than just a buzzword in biotech

As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. “Most of the companies we have seen have an AI component to support the discovery or development processes,” Francisco Dopazo, a general partner at Humboldt Fund told TechCrunch recently. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations. So to get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today. For Franck Lescure, a partner at Elaia Partners, in biotech, having an AI component isn’t an automatic deal closer. “We do not favor biotech startups with extant AI over those without: Bio-revolution is not only digital. Digital is one tool; the other major tool is the livin
Read more

Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures (Igor Bosilkovski/Forbes)

Image
Igor Bosilkovski / Forbes : Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures   —  Canadian collaborative conversational AI tool Voiceflow announced today that it has raised $20 million in a Series A round led by Felicis Ventures. from Techmeme https://ift.tt/3rFQ9St via IFTTT
Read more

Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics (Adam Rawnsley/Rolling Stone)

Image
Adam Rawnsley / Rolling Stone : Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics   —  Elon's mass firing of security staff and increased reliance on automation is going to make it easier for tyrants to shout … from Techmeme https://ift.tt/xQsF2ef via IFTTT
Read more